Check out Thomas Clancy's fundraising page - fundraise.massgeneralbrigham…
Last push before BAA 10K to support our hepatopancreatobiliary program at Mass General Brigham Cancer Institute
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Absolutely practice changing!! One of the most stunning developments in the treatment of patients with metastatic pancreatic cancer !! It is one of the rare moments in oncology which you will always remember ! Like the imatinib, trastuzumab presentations @ASCO#ASCO26@OncoAlert
I hope you didn’t miss out on @paul_wongg talk at #AHPBA26 on an externalized pancreatic stent during robotic Whipple!! Looking forward to the manuscript! 💫
@TClancyMD told me in November, two weeks post Whipple that I would enjoy a walk on the beach in March and not feel the effects of the surgery.
I doubted him.
Today I took that walk and he was right. I didn’t feel the effects of the surgery.
I even stopped to capture an image of the moment.
Praise God and thank you Dr. Clancy.
February is Gallbladder & Bile Duct Awareness Month!
New JOGS Article “Liver transplant for intrahepatic cholangiocarcinoma: current evidence & clinical practice recommendations” out now!
Congrats @RoiAnteby, @benvierra95, & @shimulshah73.
Read more: ow.ly/s2RS50Yi8sl
Looking forward to a new position as Director of Interventional Cardiology at Mass General Brigham. With incredible colleagues throughout the system, we will build the most comprehensive IC program internationally.
Tumor-agnostic ctDNA NGS was feasible in localized pancreatic cancer and captured dynamic treatment response. ctDNA absence tracked with CA19-9 drop and better outcomes.
journals.lww.com/annalsofsur…
Congrats to the GGI team for an fun BWH #Boston10K that raised money for pancreatic cancer research! Sweats, grazes and muscle cramps to show for our efforts!
@BrighamWomens@BrighamSurgery@BAA
“No children are dying on my watch,” said Rubio. It's blatantly false. Credible estimates count 190K deaths so far.
In Kenya, I am documenting for a film devastating impact, including this child's starvation & many deaths directly caused by Rubio’s actions. See my @msnbc clip
Congratulations to Kenneth Tanabe, MD, Co-Chief of MGH Division of Gastrointestinal and Oncologic Surgery, who was appointed President-elect of the Society of Surgical Oncology! The SSO is the world’s leading professional org dedicated to advancing the field of surgical oncology
Shimul Shah, MD, MHCM, new Chief of MGB Transplantation, has been appointed President-elect of the Americas HepatoPancreaticoBiliary Association! The AHPBA is one of the world’s leading professional orgs, dedicated to advancing the field of liver, pancreas, and biliary surgery.